Suppression of F-18 fluorodeoxyglucose uptake in benign uterine leiomyomas with danazol.
Tripathi
Madhavi
M
Division Of PET Imaging, Molecular Imaging and Research Centre, Institute of Nuclear Medicine and Allied Sciences, Delhi, India. madhu_deven@yahoo.com
Srivastava
Madhur
M
Garg
Gunjun
G
Jaimini
Abhinav
A
Singh
Namita
N
Souza
Maria D
MD
Kaur
Prabhjot
P
Sharma
Rajnish
R
Mandal
Anupam
A
D000328:Adult; D003613:Danazol / Q000627:therapeutic use*; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D005260:Female; D019788:Fluorodeoxyglucose F18 / Q000493:pharmacokinetics*; D006801:Humans; D007889:Leiomyoma / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000378:metabolism*; D009215:Myometrium / Q000000981:diagnostic imaging / Q000378:metabolism / Q000473:pathology; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D014057:Tomography, X-Ray Computed; D014594:Uterine Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000378:metabolism*
D004965:Estrogen Antagonists; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D003613:Danazol